A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING.
An imidazole antithyroid agent. Carbimazole is metabolized to METHIMAZOLE, which is responsible for the antithyroid activity.
Hypersecretion of THYROID HORMONES from the THYROID GLAND. Elevated levels of thyroid hormones increase BASAL METABOLIC RATE.
Agents that are used to treat hyperthyroidism by reducing the excessive production of thyroid hormones.
A dangerous life-threatening hypermetabolic condition characterized by high FEVER and dysfunction of the cardiovascular, the nervous, and the gastrointestinal systems.
Inflammatory diseases of the THYROID GLAND. Thyroiditis can be classified into acute (THYROIDITIS, SUPPURATIVE), subacute (granulomatous and lymphocytic), chronic fibrous (Riedel's), chronic lymphocytic (HASHIMOTO DISEASE), transient (POSTPARTUM THYROIDITIS), and other AUTOIMMUNE THYROIDITIS subtypes.
A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy).
Blood tests used to evaluate the functioning of the thyroid gland.
A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme.
The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
A highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the TRACHEA. It secretes THYROID HORMONES from the follicular cells and CALCITONIN from the parafollicular cells thereby regulating METABOLISM and CALCIUM level in blood, respectively.
A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA.
An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
An autosomal dominant familial disorder characterized by recurrent episodes of skeletal muscle weakness associated with falls in serum potassium levels. The condition usually presents in the first or second decade of life with attacks of trunk and leg paresis during sleep or shortly after awakening. Symptoms may persist for hours to days and generally are precipitated by exercise or a meal high in carbohydrates. (Adams et al., Principles of Neurology, 6th ed, p1483)
Natural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs.
Spontaneously remitting inflammatory condition of the THYROID GLAND, characterized by FEVER; MUSCLE WEAKNESS; SORE THROAT; severe thyroid PAIN; and an enlarged damaged gland containing GIANT CELLS. The disease frequently follows a viral infection.
An enlarged THYROID GLAND containing multiple nodules (THYROID NODULE), usually resulting from recurrent thyroid HYPERPLASIA and involution over many years to produce the irregular enlargement. Multinodular goiters may be nontoxic or may induce THYROTOXICOSIS.
A glycoprotein hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Thyrotropin stimulates THYROID GLAND by increasing the iodide transport, synthesis and release of thyroid hormones (THYROXINE and TRIIODOTHYRONINE). Thyrotropin consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the pituitary glycoprotein hormones (TSH; LUTEINIZING HORMONE and FSH), but the beta subunit is unique and confers its biological specificity.
A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
Surgical removal of the thyroid gland. (Dorland, 28th ed)
Pathological processes involving the THYROID GLAND.
A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.
Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes.
A thiourea antithyroid agent. Propythiouracil inhibits the synthesis of thyroxine and inhibits the peripheral conversion of throxine to tri-iodothyronine. It is used in the treatment of hyperthyroidism. (From Martindale, The Extra Pharmacopeoia, 30th ed, p534)
Enlargement of the THYROID GLAND that may increase from about 20 grams to hundreds of grams in human adults. Goiter is observed in individuals with normal thyroid function (euthyroidism), thyroid deficiency (HYPOTHYROIDISM), or hormone overproduction (HYPERTHYROIDISM). Goiter may be congenital or acquired, sporadic or endemic (GOITER, ENDEMIC).
Autoantibodies that bind to the thyroid-stimulating hormone (TSH) receptor (RECEPTORS, THYROTROPIN) on thyroid epithelial cells. The autoantibodies mimic TSH causing an unregulated production of thyroid hormones characteristic of GRAVES DISEASE.
Cell surface proteins that bind pituitary THYROTROPIN (also named thyroid stimulating hormone or TSH) and trigger intracellular changes of the target cells. TSH receptors are present in the nervous system and on target cells in the thyroid gland. Autoantibodies to TSH receptors are implicated in thyroid diseases such as GRAVES DISEASE and Hashimoto disease (THYROIDITIS, AUTOIMMUNE).
An immunoglobulin G, often found in the blood of hyperthyroid individuals. It stimulates the thyroid for a longer duration than does thyrotoxin and may cause hyperthyroidism in newborns due to placental transmission.
Complexes of iodine and non-ionic SURFACE-ACTIVE AGENTS acting as carrier and solubilizing agent for the iodine in water. Iodophors usually enhance bactericidal activity of iodine, reduce vapor pressure and odor, minimize staining, and allow wide dilution with water. (From Merck Index, 11th ed)
Stable iodine atoms that have the same atomic number as the element iodine, but differ in atomic weight. I-127 is the only naturally occurring stable iodine isotope.
A lithium salt, classified as a mood-stabilizing agent. Lithium ion alters the metabolism of BIOGENIC MONOAMINES in the CENTRAL NERVOUS SYSTEM, and affects multiple neurotransmission systems.
Inflammatory disease of the THYROID GLAND due to autoimmune responses leading to lymphocytic infiltration of the gland. It is characterized by the presence of circulating thyroid antigen-specific T-CELLS and thyroid AUTOANTIBODIES. The clinical signs can range from HYPOTHYROIDISM to THYROTOXICOSIS depending on the type of autoimmune thyroiditis.
The removal or interruption of some part of the parasympathetic nervous system for therapeutic or research purposes.
Disorders characterized by physical or psychological symptoms that are not real, genuine, or natural.
An acute neurological disorder characterized by the triad of ophthalmoplegia, ataxia, and disturbances of mental activity or consciousness. Eye movement abnormalities include nystagmus, external rectus palsies, and reduced conjugate gaze. THIAMINE DEFICIENCY and chronic ALCOHOLISM are associated conditions. Pathologic features include periventricular petechial hemorrhages and neuropil breakdown in the diencephalon and brainstem. Chronic thiamine deficiency may lead to KORSAKOFF SYNDROME. (Adams et al., Principles of Neurology, 6th ed, pp1139-42; Davis & Robertson, Textbook of Neuropathology, 2nd ed, pp452-3)
Intractable VOMITING that develops in early PREGNANCY and persists. This can lead to DEHYDRATION and WEIGHT LOSS.
A condition characterized by a dry, waxy type of swelling (EDEMA) with abnormal deposits of MUCOPOLYSACCHARIDES in the SKIN and other tissues. It is caused by a deficiency of THYROID HORMONES. The skin becomes puffy around the eyes and on the cheeks. The face is dull and expressionless with thickened nose and lips.
The removal or interruption of some part of the autonomic nervous system for therapeutic or research purposes.
A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, cardiovascular and cerebral circulation, brain, thyroid, and joints.
A nutritional condition produced by a deficiency of THIAMINE in the diet, characterized by anorexia, irritability, and weight loss. Later, patients experience weakness, peripheral neuropathy, headache, and tachycardia. In addition to being caused by a poor diet, thiamine deficiency in the United States most commonly occurs as a result of alcoholism, since ethanol interferes with thiamine absorption. In countries relying on polished rice as a dietary staple, BERIBERI prevalence is very high. (From Cecil Textbook of Medicine, 19th ed, p1171)
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

Thyroid disease in pregnancy. (1/258)

This review article provides a broad overview of thyroid disease and pregnancy.  (+info)

Risk of iodine-induced thyrotoxicosis after coronary angiography: an investigation in 788 unselected subjects. (2/258)

In this study, the risk of iodine-induced thyrotoxicosis in unselected patients from an iodine-deficient area was investigated. The patients were consecutively enrolled. Thyroid hormone values and urinary iodine excretion were determined before, as well as 1, 4 and 12 weeks after iodine contamination by coronary angiography. Two of 788 unselected patients developed hyperthyroidism within 12 weeks. The two patients did not belong to a risk group for iodine-induced thyrotoxicosis (i.e. old people, patients with goiter or possible thyroid autonomy, low TSH). Both patients had normal TSH levels at baseline and ultrasound of the thyroid was without evidence of nodules. The study shows that in euthyroid unselected patients from an iodine-deficient area short-term iodine contamination by contrast media rarely leads to hyperthyroidism. On account of these facts, prophylactic therapy, e.g. by perchlorate or thiamazole, is not generally recommended, because the risk of side-effects is perhaps even greater than the risk of iodine-induced thyrotoxicosis.  (+info)

Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow doppler sonography. (3/258)

OBJECTIVE: Thyroid blood flow is greatly enhanced in untreated Graves' disease, but it is not known whether it is due to thyroid hormone excess or to thyroid hyperstimulation by TSH-receptor antibody. To address this issue in vivo patients with different thyroid disorders were submitted to color flow doppler sonography (CFDS). SUBJECTS AND METHODS: We investigated 24 normal subjects, and 78 patients with untreated hyperthyroidism (49 with Graves' hyperthyroidism, 24 with toxic adenoma, and 5 patients with TSH-secreting pituitary adenoma (TSHoma)), 19 patients with thyrotoxicosis (7 with thyrotoxicosis factitia, and 12 with subacute thyroiditis), 37 euthyroid patients with goitrous Hashimoto's thyroiditis, and 21 untreated hypothyroid patients with Hashimoto's thyroiditis. RESULTS: Normal subjects had CFDS pattern 0 (absent or minimal intraparenchimal spots) and mean intraparenchimal peak systolic velocity (PSV) of 4.8+/-1.2cm/s. Patients with spontaneous hyperthyroidism due to Graves' disease, TSHoma, and toxic adenoma had significantly increased PSV (P<0.0001, P=0.0004, P<0.0001 respectively vs controls) and CFDS pattern. Patients with Graves' disease had CFDS pattern II (mild increase of color flow doppler signal) in 10 (20%) and pattern III (marked increase) in 39 cases (80%). Mean PSV was 15+/-3cm/s. Patients with toxic adenoma had CFDS pattern I (presence of parenchymal blood flow with patchy uneven distribution) in 2 (8%), pattern II in 16 (70%) and pattern III in 5 (22%). Mean PSV was 11+/-2.4cm/s. Patients with TSHoma showed CFDS pattern I in one case (20%) and pattern II in 4 (80%). Mean PSV was 14.8+/-4.2cm/s. Patients with thyrotoxicosis had normal PSV (4.2+/-1. 1cm/s in subacute thyroiditis, 4+/-0.8cm/s in thyrotoxicosis factitia, P=not significant vs controls) and CFDS pattern 0. Untreated euthyroid patients with goitrous Hashimoto's thyroiditis had CFDS pattern 0, and mean PSV (4.3+/-0.9cm/s; P=not significant vs controls). Untreated hypothyroid patients with goitrous Hashimoto's thyroiditis had CFDS pattern I in 14 cases (67%), pattern II in 4 (19%) and pattern 0 in 3 (14%) and mean PSV (5.6+/-1. 4cm/s) was higher than that of controls (P=0.026). CONCLUSIONS: An increase in both intrathyroidal vascularity and blood velocity was observed in patients with spontaneous hyperthyroidism but not in thyrotoxicosis due to either ingestion of thyroid hormones or to a thyroidal destructive process. The slightly increased vascularity and blood velocity observed in patients with hypothyroid Hashimoto's thyroiditis suggests that thyroid stimulation by either TSH-receptor antibody or TSH is responsible for the increased thyroid blood flow.  (+info)

Measurement of red blood cell zinc concentration with Zn-test kit: discrimination between hyperthyroid Graves' disease and transient thyrotoxicosis. (4/258)

We have previously reported in patients with hyperthyroidism that the red blood cell (RBC) zinc (Zn) concentration reflects the mean thyroid hormone concentration over the preceding months. In the present study, the concentration of RBC Zn was measured by a simple and easy method with a Zn-test Wako kit. Within-run and between-run precision were 1.4% and 1.3%, respectively. The relationship between RBC concentration and dilution was linear. The average recovery was 103%. A good correlation (r=0.97) was obtained between this method and atomic absorption spectrophotometry. The mean concentration of RBC Zn in 39 euthyroid controls was 12.6 +/- 1.3 mg/l, ranging from 10.4 to 15.1 mg/l. The RBC Zn concentrations in 38 patients with Graves' disease, in 10 patients with silent thyroiditis and in 3 patients with gestational thyrotoxicosis were 7.3 +/- 1.6 (3.2-9.8), 12.0 +/- 1.6 (9.5-14.2) and 11.8 +/- 1.7 (10.5-13.7) mg/l, respectively. The concentration of RBC Zn was able to differentiate hyperthyroid Graves' disease from transient thyrotoxicosis except in 1 case and was a better index than TSH-binding inhibitory immunoglobulin. These results indicate that measuring RBC Zn with the Zinc-test Wako kit is very useful in differentiating hyperthyroid Graves' disease from transient thyrotoxicosis.  (+info)

Good prognosis in thyroid cancer found incidentally at surgery for thyrotoxicosis. (5/258)

An analysis of the outcome of thyroid carcinoma incidentally discovered in patients undergoing surgery for hyperthyroidism is presented. Among 986 patients with differentiated thyroid cancer, 23 had presented with symptoms and signs of hyperthyroidism. Graves' disease was diagnosed in 11, multinodular goitre in eight and toxic adenoma in four. Following thyroidectomy, histology revealed papillary (18), follicular (four) and Hurthle cell (one) carcinoma. Tumour size ranged from 4 mm to 5.5 cm, multifocality was detected in three patients, and lymph node involvement in one. Two patients (one with associated Graves' disease, one with multinodular goitre) relapsed locally and required further surgery; one developed distant metastases and died 7 years after initial presentation. Two patients died of unrelated causes; the remaining 20 patients are alive and well with a median follow-up of 16 (1-34) years. Differentiated thyroid cancer found incidentally at surgery for hyperthyroidism has a good prognosis.  (+info)

Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan. (6/258)

Since amiodarone was introduced in Japan in 1992, the incidence of the drug-induced thyroid dysfunction has been increasing. We studied the thyroid function of 13 patients with amiodarone-induced thyrotoxicosis (AIT) and 11 patients with amiodarone-associated hypothyroidism (AAH) who had been referred to our Institute in the last 6 years. AIT and AAH developed after 39+/-21 and 20+/-16 months of amiodarone treatment, respectively. One patient developed AAH followed by AIT. The AIT ranged from subclinical to overt thyrotoxicosis. Four patients with moderate to marked AIT were treated with methimazole. Their thyrotoxicosis persisted for 3 to 9 months, despite administration of antithyroid agents. One patient with mild thyrotoxicosis was treated with prednisolone, resulting in a euthyroid state in a few months. Eight patients with asymptomatic to moderate thyrotoxicosis resolved spontaneously without any treatment. In four asymptomatic patients with AIT, serum levels of T3 and T4 were in the upper normal range or slightly high (< 12 microg/dl), accompanied by suppressed TSH (<0.1 microU/ml) and high thyroglobulin levels, suggesting destruction-induced thyrotoxicosis. Such a subclinical thyrotoxicosis developed repeatedly in one patient. Ultrasonographic studies revealed no nodular lesion in the thyroid, and color flow Doppler sonography demonstrated no hypervascularity in the thyroid gland in any AIT patient. Although it is postulated in Europe that there are two types of AIT, namely type I, which develops in patients with latent Graves' disease or toxic multinodular goiter, and type II, which develops in an apparently normal thyroid as destructive thyroiditis, all AIT patients we have seen so far had developed destructive type AIT. Sufficient intake of iodide and a very low incidence of toxic multinodular goiter may account for the rare incidence of type I AIT in our country. Mild to moderate AIT resolved spontaneously without discontinuing amiodarone, but it was discontinued in two of 13 AIT patients because of extrathyroidal adverse reactions.  (+info)

Diabetic ketoacidosis precipitated by thyrotoxicosis. (7/258)

We report two patients with type 1 diabetes mellitus, previously well controlled with good compliance, presenting with unexplained diabetic ketoacidosis. Following initial correction of the metabolic disorder, persisting tachycardia lead to the diagnosis of thyrotoxicosis. In both cases, treatment with propranolol and carbimazole helped in the stabilization of their metabolic states. Although thyrotoxicosis is known to destabilize diabetes control, we can find no reports of it precipitating diabetic ketoacidosis.  (+info)

Clinical presentation of thyroid dysfunction and Addison's disease in young adults with type 1 diabetes. (8/258)

In a clinic population of 509 type 1 diabetic patients aged 16-45 years, 5.5% had received treatment for thyroid disorders (20 hypothyroid, three males; eight thyrotoxicosis, four males), and Addison's disease was present in four patients (0.8%, one male). In all patients, type 1 diabetes preceded the diagnosis of the other autoimmune disorder. The clinical presentation of hypothyroidism was usually insidious with few symptoms, although an increased frequency of hypoglycaemic symptoms and/or raised serum cholesterol levels often prompted thyroid function testing. In contrast, the patients with thyrotoxicosis had florid symptoms, weight loss (mean 8.12 kg), palpable goitres, increasing insulin requirements, and low cholesterol levels. Six patients did not achieve remission or had recurrent thyrotoxicosis after oral antithyroid treatment and required 131I or thyroid surgery. A family history of autoimmune disease was present in 25% of patients with thyroid disorders (seven thyrotoxic and one hypothyroid) and in three of the four patients with Addison's disease. In this population of young adult type 1 diabetic patients, appropriate tests for thyroid dysfunction and Addison's disease should be carried out if there is clinical suspicion and/or unexplained changes in diabetic metabolic control or serum cholesterol. Careful follow-up of patients with a family history of these conditions is recommended.  (+info)

Thyrotoxicosis is a medical condition that results from an excess of thyroid hormones in the body, leading to an overactive metabolic state. It can be caused by various factors such as Graves' disease, toxic adenoma, Plummer's disease, or excessive intake of thyroid hormone medication. Symptoms may include rapid heart rate, weight loss, heat intolerance, tremors, and increased sweating, among others. Thyrotoxicosis is not a diagnosis itself but a manifestation of various underlying thyroid disorders. Proper diagnosis and management are crucial to prevent complications and improve quality of life.

Carbimazole is an antithyroid medication that is primarily used to manage hyperthyroidism, a condition characterized by an overactive thyroid gland that produces excessive amounts of thyroid hormones. The drug works by inhibiting the enzyme responsible for producing these hormones, thereby reducing their levels in the body and alleviating symptoms associated with the disorder.

Hyperthyroidism can manifest as various signs and symptoms, including rapid heartbeat, weight loss, heat intolerance, tremors, anxiety, and sleep disturbances. Common causes of hyperthyroidism include Graves' disease, toxic adenoma, and thyroiditis.

Carbimazole is a prodrug that gets converted to its active metabolite, methimazole, in the liver. Methimazole inhibits the activity of thyroperoxidase, an enzyme involved in the synthesis of thyroid hormones triiodothyronine (T3) and thyroxine (T4). By blocking this enzyme, carbimazole reduces the production of T3 and T4, ultimately helping to control hyperthyroidism.

The medication is typically administered orally in tablet form, with dosages varying depending on individual patient needs and response to treatment. Common side effects of carbimazole include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. Rare but severe adverse reactions may include agranulocytosis (a severe decrease in white blood cells), aplastic anemia (a condition where the bone marrow fails to produce sufficient numbers of blood cells), and hepatotoxicity (liver damage).

Patients taking carbimazole should be closely monitored for signs of adverse reactions, and regular blood tests are necessary to assess thyroid hormone levels and potential side effects. Pregnant women should avoid using carbimazole due to the risk of birth defects in the developing fetus. In such cases, alternative antithyroid medications like propylthiouracil may be prescribed instead.

In summary, carbimazole is an antithyroid medication used primarily for managing hyperthyroidism by inhibiting thyroperoxidase and reducing the production of thyroid hormones T3 and T4. While effective, it carries potential risks and side effects that necessitate close monitoring during treatment.

Hyperthyroidism is a medical condition characterized by an excessive production and release of thyroid hormones from the thyroid gland, leading to an increased metabolic rate in various body systems. The thyroid gland, located in the front of the neck, produces two main thyroid hormones: triiodothyronine (T3) and thyroxine (T4). These hormones play crucial roles in regulating many bodily functions, including heart rate, digestion, energy levels, and mood.

In hyperthyroidism, the elevated levels of T3 and T4 can cause a wide range of symptoms, such as rapid heartbeat, weight loss, heat intolerance, increased appetite, tremors, anxiety, and sleep disturbances. Some common causes of hyperthyroidism include Graves' disease, toxic adenoma, Plummer's disease (toxic multinodular goiter), and thyroiditis. Proper diagnosis and treatment are essential to manage the symptoms and prevent potential complications associated with this condition.

Antithyroid agents are a class of medications that are used to treat hyperthyroidism, a condition in which the thyroid gland produces too much thyroid hormone. These medications work by inhibiting the production of thyroid hormones in the thyroid gland. There are several types of antithyroid agents available, including:

1. Propylthiouracil (PTU): This medication works by blocking the enzyme that is needed to produce thyroid hormones. It also reduces the conversion of thyroxine (T4) to triiodothyronine (T3), another thyroid hormone, in peripheral tissues.
2. Methimazole: This medication works similarly to propylthiouracil by blocking the enzyme that is needed to produce thyroid hormones. However, it does not affect the conversion of T4 to T3 in peripheral tissues.
3. Carbimazole: This medication is converted to methimazole in the body and works similarly to block the production of thyroid hormones.

Antithyroid agents are usually taken orally, and their effects on thyroid hormone production begin within a few hours after ingestion. However, it may take several weeks for patients to notice an improvement in their symptoms. These medications can have side effects, including rash, hives, and joint pain. In rare cases, they can cause liver damage or agranulocytosis, a condition in which the body does not produce enough white blood cells.

It is important to note that antithyroid agents do not cure hyperthyroidism; they only treat the symptoms by reducing thyroid hormone production. Therefore, patients may need to take these medications for several months or even years, depending on their individual circumstances. In some cases, surgery or radioactive iodine therapy may be recommended as alternative treatments for hyperthyroidism.

A thyroid crisis, also known as thyrotoxic crisis or storm, is a rare but life-threatening condition characterized by an exaggerated response to the excess production of thyroid hormones (thyrotoxicosis). This condition can lead to severe hypermetabolic state, multi-organ dysfunction, and cardiovascular collapse if not promptly diagnosed and treated.

Thyroid crisis is often triggered by a stressful event, infection, or surgery in individuals with uncontrolled or poorly managed hyperthyroidism, particularly those with Graves' disease. The symptoms of thyroid crisis include high fever, tachycardia (rapid heart rate), hypertension (high blood pressure), agitation, confusion, delirium, vomiting, diarrhea, and sometimes coma.

The diagnosis of thyroid crisis is based on the clinical presentation, laboratory tests, and imaging studies. Treatment typically involves hospitalization in an intensive care unit, administration of medications to block the production and release of thyroid hormones, control heart rate and rhythm, correct electrolyte imbalances, and provide supportive care until the patient's condition stabilizes.

Thyroiditis is a general term that refers to inflammation of the thyroid gland. It can be caused by various factors such as infections, autoimmune disorders, or medications. Depending on the cause and severity, thyroiditis may lead to overproduction (hyperthyroidism) or underproduction (hypothyroidism) of thyroid hormones, or it can result in a temporary or permanent loss of thyroid function.

There are several types of thyroiditis, including:

1. Hashimoto's thyroiditis - an autoimmune disorder where the body attacks and damages the thyroid gland, leading to hypothyroidism.
2. Subacute granulomatous thyroiditis (De Quervain's thyroiditis) - often follows a viral infection and results in painful inflammation of the thyroid gland, causing hyperthyroidism followed by hypothyroidism.
3. Silent thyroiditis - an autoimmune disorder similar to Hashimoto's thyroiditis but without symptoms like pain or tenderness; it can cause temporary hyperthyroidism and later hypothyroidism.
4. Postpartum thyroiditis - occurs in women after childbirth, causing inflammation of the thyroid gland leading to hyperthyroidism followed by hypothyroidism.
5. Acute suppurative thyroiditis - a rare bacterial infection that causes painful swelling and redness of the thyroid gland, usually requiring antibiotics for treatment.

Symptoms of thyroiditis depend on whether it leads to hyperthyroidism or hypothyroidism. Hyperthyroidism symptoms include rapid heartbeat, weight loss, heat intolerance, anxiety, and tremors. Hypothyroidism symptoms include fatigue, weight gain, cold intolerance, constipation, dry skin, and depression. Treatment varies depending on the type of thyroiditis and its severity.

Graves' disease is defined as an autoimmune disorder that leads to overactivity of the thyroid gland (hyperthyroidism). It results when the immune system produces antibodies that stimulate the thyroid gland, causing it to produce too much thyroid hormone. This can result in a variety of symptoms such as rapid heartbeat, weight loss, heat intolerance, and bulging eyes (Graves' ophthalmopathy). The exact cause of Graves' disease is unknown, but it is more common in women and people with a family history of the disorder. Treatment may include medications to control hyperthyroidism, radioactive iodine therapy to destroy thyroid tissue, or surgery to remove the thyroid gland.

Thyroid function tests (TFTs) are a group of blood tests that assess the functioning of the thyroid gland, which is a small butterfly-shaped gland located in the front of the neck. The thyroid gland produces hormones that regulate metabolism, growth, and development in the body.

TFTs typically include the following tests:

1. Thyroid-stimulating hormone (TSH) test: This test measures the level of TSH, a hormone produced by the pituitary gland that regulates the production of thyroid hormones. High levels of TSH may indicate an underactive thyroid gland (hypothyroidism), while low levels may indicate an overactive thyroid gland (hyperthyroidism).
2. Thyroxine (T4) test: This test measures the level of T4, a hormone produced by the thyroid gland. High levels of T4 may indicate hyperthyroidism, while low levels may indicate hypothyroidism.
3. Triiodothyronine (T3) test: This test measures the level of T3, another hormone produced by the thyroid gland. High levels of T3 may indicate hyperthyroidism, while low levels may indicate hypothyroidism.
4. Thyroid peroxidase antibody (TPOAb) test: This test measures the level of TPOAb, an antibody that attacks the thyroid gland and can cause hypothyroidism.
5. Thyroglobulin (Tg) test: This test measures the level of Tg, a protein produced by the thyroid gland. It is used to monitor the treatment of thyroid cancer.

These tests help diagnose and manage various thyroid disorders, including hypothyroidism, hyperthyroidism, thyroiditis, and thyroid cancer.

Methimazole is an anti-thyroid medication that is primarily used to treat hyperthyroidism, a condition in which the thyroid gland produces excessive amounts of thyroid hormones. It works by inhibiting the enzyme thyroperoxidase, which is essential for the production of thyroid hormones. By blocking this enzyme, methimazole reduces the amount of thyroid hormones produced by the thyroid gland, helping to restore normal thyroid function.

Methimazole is available in oral tablet form and is typically taken two to three times a day. Common side effects of methimazole include nausea, vomiting, skin rashes, and joint pain. In rare cases, it can cause more serious side effects such as liver damage or agranulocytosis (a severe decrease in white blood cell count).

It is important to note that methimazole should only be used under the close supervision of a healthcare provider, as regular monitoring of thyroid function and potential side effects is necessary. Additionally, it may take several weeks or months of treatment with methimazole before thyroid function returns to normal.

Thyroxine (T4) is a type of hormone produced and released by the thyroid gland, a small butterfly-shaped endocrine gland located in the front of your neck. It is one of two major hormones produced by the thyroid gland, with the other being triiodothyronine (T3).

Thyroxine plays a crucial role in regulating various metabolic processes in the body, including growth, development, and energy expenditure. Specifically, T4 helps to control the rate at which your body burns calories for energy, regulates protein, fat, and carbohydrate metabolism, and influences the body's sensitivity to other hormones.

T4 is produced by combining iodine and tyrosine, an amino acid found in many foods. Once produced, T4 circulates in the bloodstream and gets converted into its active form, T3, in various tissues throughout the body. Thyroxine has a longer half-life than T3, which means it remains active in the body for a more extended period.

Abnormal levels of thyroxine can lead to various medical conditions, such as hypothyroidism (underactive thyroid) or hyperthyroidism (overactive thyroid). These conditions can cause a range of symptoms, including weight gain or loss, fatigue, mood changes, and changes in heart rate and blood pressure.

The thyroid gland is a major endocrine gland located in the neck, anterior to the trachea and extends from the lower third of the Adams apple to the suprasternal notch. It has two lateral lobes, connected by an isthmus, and sometimes a pyramidal lobe. This gland plays a crucial role in the metabolism, growth, and development of the human body through the production of thyroid hormones (triiodothyronine/T3 and thyroxine/T4) and calcitonin. The thyroid hormones regulate body temperature, heart rate, and the production of protein, while calcitonin helps in controlling calcium levels in the blood. The function of the thyroid gland is controlled by the hypothalamus and pituitary gland through the thyroid-stimulating hormone (TSH).

Hypothyroidism is a medical condition where the thyroid gland, which is a small butterfly-shaped gland located in the front of your neck, does not produce enough thyroid hormones. This results in a slowing down of the body's metabolic processes, leading to various symptoms such as fatigue, weight gain, constipation, cold intolerance, dry skin, hair loss, muscle weakness, and depression.

The two main thyroid hormones produced by the thyroid gland are triiodothyronine (T3) and thyroxine (T4). These hormones play crucial roles in regulating various bodily functions, including heart rate, body temperature, and energy levels. In hypothyroidism, the production of these hormones is insufficient, leading to a range of symptoms that can affect multiple organ systems.

Hypothyroidism can be caused by several factors, including autoimmune disorders (such as Hashimoto's thyroiditis), surgical removal of the thyroid gland, radiation therapy for neck cancer, certain medications, and congenital defects. Hypothyroidism is typically diagnosed through blood tests that measure levels of TSH (thyroid-stimulating hormone), T3, and T4. Treatment usually involves taking synthetic thyroid hormones to replace the missing hormones and alleviate symptoms.

Amiodarone is a Class III antiarrhythmic medication used to treat and prevent various types of irregular heart rhythms (arrhythmias). It works by stabilizing the electrical activity of the heart and slowing down the nerve impulses in the heart tissue. Amiodarone is available in oral tablet and injection forms.

The medical definition of 'Amiodarone' is:

A benzofuran derivative with Class III antiarrhythmic properties, used for the treatment of ventricular arrhythmias. It has a relatively slow onset of action and is therefore not useful in acute situations. Additionally, it has negative inotropic effects and may exacerbate heart failure. The most serious adverse effect is pulmonary fibrosis, which occurs in approximately 1-2% of patients. Other important side effects include corneal microdeposits, hepatotoxicity, thyroid dysfunction, and photosensitivity. Amiodarone has a very long half-life (approximately 50 days) due to its extensive tissue distribution. It is metabolized by the liver and excreted in bile and urine.

Sources:

1. UpToDate - Amiodarone use in adults: Indications, dosing, and adverse effects.
2. Micromedex - Amiodarone.
3. Drugs.com - Amiodarone.

Hypokalemic Periodic Paralysis (HPP) is a group of rare inherited disorders characterized by episodes of muscle weakness or paralysis, often associated with low potassium levels in the blood (hypokalemia). During an attack, muscles may become weak or fully paralyzed, typically affecting the legs and arms. The episodes can last from several hours to days. HPP is caused by genetic mutations that affect ion channels in muscle cells, leading to an imbalance of electrolytes and impaired muscle function. There are two main types: primary (or classic) HPP and secondary HPP. Primary HPP is further divided into thyrotoxic HPP and normokalemic HPP. Secondary HPP can be caused by various factors, such as medications or underlying medical conditions that cause hypokalemia.

Thyroid hormones are hormones produced and released by the thyroid gland, a small endocrine gland located in the neck that helps regulate metabolism, growth, and development in the human body. The two main thyroid hormones are triiodothyronine (T3) and thyroxine (T4), which contain iodine atoms. These hormones play a crucial role in various bodily functions, including heart rate, body temperature, digestion, and brain development. They help regulate the rate at which your body uses energy, affects how sensitive your body is to other hormones, and plays a vital role in the development and differentiation of all cells of the human body. Thyroid hormone levels are regulated by the hypothalamus and pituitary gland through a feedback mechanism that helps maintain proper balance.

Subacute thyroiditis, also known as de Quervain's thyroiditis or granulomatous thyroiditis, is a inflammatory disorder of the thyroid gland. It is characterized by the presence of granulomas, which are collections of immune cells, within the thyroid tissue. The condition often follows an upper respiratory infection and is more common in women than men.

Subacute thyroiditis typically presents with pain and tenderness in the front of the neck, along with systemic symptoms such as fatigue, weakness, and low-grade fever. The disorder can cause hyperthyroidism (overactive thyroid) initially, followed by hypothyroidism (underactive thyroid) as the gland becomes damaged and inflamed. In some cases, the thyroid function may return to normal on its own after several months. Treatment typically involves anti-inflammatory medications to reduce pain and inflammation, and beta blockers to manage symptoms of hyperthyroidism.

A goiter is an abnormal enlargement of the thyroid gland, which is a butterfly-shaped endocrine gland located in the front of the neck. Goiters can be either diffuse (uniformly enlarged) or nodular (lumpy with distinct nodules). Nodular goiter refers to a thyroid gland that has developed one or more discrete lumps or nodules while the remaining tissue is normal or may also be diffusely enlarged.

Nodular goiters can be classified into two types: multinodular goiter and solitary thyroid nodule. Multinodular goiter consists of multiple nodules in the thyroid gland, while a solitary thyroid nodule is an isolated nodule within an otherwise normal or diffusely enlarged thyroid gland.

The majority of nodular goiters are benign and do not cause symptoms. However, some patients may experience signs and symptoms related to compression of nearby structures (such as difficulty swallowing or breathing), hyperthyroidism (overactive thyroid), or hypothyroidism (underactive thyroid). The evaluation of a nodular goiter typically includes a physical examination, imaging studies like ultrasound, and sometimes fine-needle aspiration biopsy to determine the nature of the nodules and assess the risk of malignancy. Treatment options depend on various factors, including the size and number of nodules, the presence of compressive symptoms, and the patient's thyroid function.

Thyrotropin, also known as thyroid-stimulating hormone (TSH), is a hormone secreted by the anterior pituitary gland. Its primary function is to regulate the production and release of thyroxine (T4) and triiodothyronine (T3) hormones from the thyroid gland. Thyrotropin binds to receptors on the surface of thyroid follicular cells, stimulating the uptake of iodide and the synthesis and release of T4 and T3. The secretion of thyrotropin is controlled by the hypothalamic-pituitary-thyroid axis: thyrotropin-releasing hormone (TRH) from the hypothalamus stimulates the release of thyrotropin, while T3 and T4 inhibit its release through a negative feedback mechanism.

Triiodothyronine (T3) is a thyroid hormone, specifically the active form of thyroid hormone, that plays a critical role in the regulation of metabolism, growth, and development in the human body. It is produced by the thyroid gland through the iodination and coupling of the amino acid tyrosine with three atoms of iodine. T3 is more potent than its precursor, thyroxine (T4), which has four iodine atoms, as T3 binds more strongly to thyroid hormone receptors and accelerates metabolic processes at the cellular level.

In circulation, about 80% of T3 is bound to plasma proteins, while the remaining 20% is unbound or free, allowing it to enter cells and exert its biological effects. The primary functions of T3 include increasing the rate of metabolic reactions, promoting protein synthesis, enhancing sensitivity to catecholamines (e.g., adrenaline), and supporting normal brain development during fetal growth and early infancy. Imbalances in T3 levels can lead to various medical conditions, such as hypothyroidism or hyperthyroidism, which may require clinical intervention and management.

Thyroidectomy is a surgical procedure where all or part of the thyroid gland is removed. The thyroid gland is a butterfly-shaped endocrine gland located in the neck, responsible for producing hormones that regulate metabolism, growth, and development.

There are different types of thyroidectomy procedures, including:

1. Total thyroidectomy: Removal of the entire thyroid gland.
2. Partial (or subtotal) thyroidectomy: Removal of a portion of the thyroid gland.
3. Hemithyroidectomy: Removal of one lobe of the thyroid gland, often performed to treat benign solitary nodules or differentiated thyroid cancer.

Thyroidectomy may be recommended for various reasons, such as treating thyroid nodules, goiter, hyperthyroidism (overactive thyroid), or thyroid cancer. Potential risks and complications of the procedure include bleeding, infection, damage to nearby structures like the parathyroid glands and recurrent laryngeal nerve, and hypoparathyroidism or hypothyroidism due to removal of or damage to the parathyroid glands or thyroid gland, respectively. Close postoperative monitoring and management are essential to minimize these risks and ensure optimal patient outcomes.

Thyroid diseases are a group of conditions that affect the function and structure of the thyroid gland, a small butterfly-shaped endocrine gland located in the base of the neck. The thyroid gland produces hormones that regulate many vital functions in the body, including metabolism, growth, and development.

Thyroid diseases can be classified into two main categories: hypothyroidism and hyperthyroidism. Hypothyroidism occurs when the thyroid gland does not produce enough hormones, leading to symptoms such as fatigue, weight gain, cold intolerance, constipation, and depression. Hyperthyroidism, on the other hand, occurs when the thyroid gland produces too much hormone, resulting in symptoms such as weight loss, heat intolerance, rapid heart rate, tremors, and anxiety.

Other common thyroid diseases include:

1. Goiter: an enlargement of the thyroid gland that can be caused by iodine deficiency or autoimmune disorders.
2. Thyroid nodules: abnormal growths on the thyroid gland that can be benign or malignant.
3. Thyroid cancer: a malignant tumor of the thyroid gland that requires medical treatment.
4. Hashimoto's disease: an autoimmune disorder that causes chronic inflammation of the thyroid gland, leading to hypothyroidism.
5. Graves' disease: an autoimmune disorder that causes hyperthyroidism and can also lead to eye problems and skin changes.

Thyroid diseases are diagnosed through a combination of physical examination, medical history, blood tests, and imaging studies such as ultrasound or CT scan. Treatment options depend on the specific type and severity of the disease and may include medication, surgery, or radioactive iodine therapy.

Iodine is an essential trace element that is necessary for the production of thyroid hormones in the body. These hormones play crucial roles in various bodily functions, including growth and development, metabolism, and brain development during pregnancy and infancy. Iodine can be found in various foods such as seaweed, dairy products, and iodized salt. In a medical context, iodine is also used as an antiseptic to disinfect surfaces, wounds, and skin infections due to its ability to kill bacteria, viruses, and fungi.

Iodine radioisotopes are radioactive isotopes of the element iodine, which decays and emits radiation in the form of gamma rays. Some commonly used iodine radioisotopes include I-123, I-125, I-131. These radioisotopes have various medical applications such as in diagnostic imaging, therapy for thyroid disorders, and cancer treatment.

For example, I-131 is commonly used to treat hyperthyroidism and differentiated thyroid cancer due to its ability to destroy thyroid tissue. On the other hand, I-123 is often used in nuclear medicine scans of the thyroid gland because it emits gamma rays that can be detected by a gamma camera, allowing for detailed images of the gland's structure and function.

It is important to note that handling and administering radioisotopes require specialized training and safety precautions due to their radiation-emitting properties.

Propylthiouracil is a medication that is primarily used to treat hyperthyroidism, a condition characterized by an overactive thyroid gland that produces too much thyroid hormone. The medication works by inhibiting the production of thyroid hormones in the body. It belongs to a class of drugs called antithyroid agents or thionamides.

In medical terms, propylthiouracil is defined as an antithyroid medication used to manage hyperthyroidism due to Graves' disease or toxic adenoma. It acts by inhibiting the synthesis of thyroid hormones, triiodothyronine (T3) and thyroxine (T4), in the thyroid gland. Propylthiouracil also reduces the peripheral conversion of T4 to T3. The medication is available as a tablet for oral administration and is typically prescribed at a starting dose of 100-150 mg three times daily, with adjustments made based on the patient's response and thyroid function tests.

It's important to note that propylthiouracil should be used under the close supervision of a healthcare provider due to potential side effects and risks associated with its use. Regular monitoring of thyroid function tests is necessary during treatment, and patients should promptly report any signs or symptoms of adverse reactions to their healthcare provider.

Goiter is a medical term that refers to an enlarged thyroid gland. The thyroid gland is a small, butterfly-shaped gland located in the front of your neck below the larynx or voice box. It produces hormones that regulate your body's metabolism, growth, and development.

Goiter can vary in size and may be visible as a swelling at the base of the neck. It can be caused by several factors, including iodine deficiency, autoimmune disorders, thyroid cancer, pregnancy, or the use of certain medications. Depending on the underlying cause and the severity of the goiter, treatment options may include medication, surgery, or radioactive iodine therapy.

Immunoglobulins, Thyroid-Stimulating (TSI), are autoantibodies that bind to the thyroid-stimulating hormone receptor (TSHR) on the surface of thyroid cells. These antibodies mimic the action of TSH and stimulate the growth and function of the thyroid gland, leading to excessive production of thyroid hormones. This results in a condition known as Graves' disease, which is characterized by hyperthyroidism, goiter, and sometimes ophthalmopathy (eye problems). The presence and titer of TSIs are used in the diagnosis of Graves' disease.

Thyrotropin receptors (TSHRs) are a type of G protein-coupled receptor found on the surface of cells in the thyroid gland. They bind to thyroid-stimulating hormone (TSH), which is produced and released by the pituitary gland. When TSH binds to the TSHR, it activates a series of intracellular signaling pathways that stimulate the production and release of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). These hormones are important for regulating metabolism, growth, and development in the body. Mutations in the TSHR gene can lead to various thyroid disorders, such as hyperthyroidism or hypothyroidism.

A long-acting thyroid stimulator (LATS) is a type of antibody that can stimulate the thyroid gland to produce excess thyroid hormones over an extended period. These antibodies are typically present in individuals with Graves' disease, an autoimmune disorder characterized by hyperthyroidism, goiter, and sometimes eye changes (Graves' ophthalmopathy).

LATS binds to the TSH receptor on thyroid cells, mimicking the action of thyroid-stimulating hormone (TSH) and leading to increased production and release of thyroxine (T4) and triiodothyronine (T3), resulting in hyperthyroidism. The "long-acting" nature of these antibodies distinguishes them from other TSH receptor antibodies, which may have a more transient effect on thyroid function.

Iodophors are antiseptic solutions or preparations that contain iodine complexed with a solubilizing agent, usually a nonionic surfactant. The most common example is povidone-iodine (polyvinylpyrrolidone-iodine). Iodophors are widely used for skin disinfection before surgical procedures and injections, as well as for the treatment of wounds and burns.

The advantage of iodophors over traditional tincture of iodine is that they provide a more sustained release of iodine, which results in a longer-lasting antimicrobial effect while being less irritating to the skin. The complexation with the solubilizing agent also helps to reduce staining of the skin and clothing compared to traditional iodine solutions.

Iodine isotopes are different forms of the chemical element iodine, which have different numbers of neutrons in their nuclei. Iodine has a total of 53 protons in its nucleus, and its stable isotope, iodine-127, has 74 neutrons, giving it a mass number of 127. However, there are also radioactive isotopes of iodine, which have different numbers of neutrons and are therefore unstable.

Radioactive isotopes of iodine emit radiation as they decay towards a stable state. For example, iodine-131 is a commonly used isotope in medical imaging and therapy, with a half-life of about 8 days. It decays by emitting beta particles and gamma rays, making it useful for treating thyroid cancer and other conditions that involve overactive thyroid glands.

Other radioactive iodine isotopes include iodine-123, which has a half-life of about 13 hours and is used in medical imaging, and iodine-125, which has a half-life of about 60 days and is used in brachytherapy (a type of radiation therapy that involves placing radioactive sources directly into or near tumors).

It's important to note that exposure to radioactive iodine isotopes can be harmful, especially if it occurs through inhalation or ingestion. This is because the iodine can accumulate in the thyroid gland and cause damage over time. Therefore, appropriate safety measures must be taken when handling or working with radioactive iodine isotopes.

Lithium carbonate is a medical inorganic salt that is commonly used as a medication, particularly in the treatment of bipolar disorder. It works by stabilizing mood and reducing the severity and frequency of manic episodes. Lithium carbonate is available in immediate-release and extended-release forms, and it is typically taken orally in the form of tablets or capsules.

The medical definition of lithium carbonate is: "A white, crystalline powder used as a mood-stabilizing drug, primarily in the treatment of bipolar disorder. It acts by reducing the availability of sodium and potassium ions within nerve cells, which alters the electrical activity of the brain and helps to regulate mood. Lithium carbonate is also used in the treatment of cluster headaches and to reduce aggression in patients with behavioral disorders."

It's important to note that lithium carbonate requires careful medical supervision due to its narrow therapeutic index, meaning there is a small range between an effective dose and a toxic one. Regular monitoring of blood levels is necessary to ensure safe and effective treatment.

Autoimmune thyroiditis, also known as Hashimoto's disease, is a chronic inflammation of the thyroid gland caused by an autoimmune response. In this condition, the immune system produces antibodies that attack and damage the thyroid gland, leading to hypothyroidism (underactive thyroid). The thyroid gland may become enlarged (goiter), and symptoms can include fatigue, weight gain, cold intolerance, constipation, dry skin, and depression. Autoimmune thyroiditis is more common in women than men and tends to run in families. It is often associated with other autoimmune disorders such as rheumatoid arthritis, Addison's disease, and type 1 diabetes. The diagnosis is typically made through blood tests that measure levels of thyroid hormones and antibodies. Treatment usually involves thyroid hormone replacement therapy to manage the symptoms of hypothyroidism.

Parasympathectomy is a surgical procedure that involves the interruption or removal of part of the parasympathetic nervous system, which is a division of the autonomic nervous system. This type of surgery is typically performed to help manage certain medical conditions such as hyperhidrosis (excessive sweating), Raynaud's disease, and some types of chronic pain.

The parasympathetic nervous system helps regulate many automatic functions in the body, including heart rate, digestion, and respiration. By interrupting or removing portions of this system, a parasympathectomy can help to reduce excessive sweating, improve circulation, or alleviate pain. However, it's important to note that this type of surgery carries risks and potential complications, and is typically only considered as a last resort when other treatments have failed.

Factitious disorders are a group of mental health conditions in which a person deliberately acts as if they have a physical or mental illness when they are not actually experiencing the symptoms. This is also sometimes referred to as "Munchausen syndrome" or "Munchausen by proxy" when it involves caregivers exaggerating, fabricating, or inducing symptoms in another person, typically a child.

People with factitious disorders may go to great lengths to deceive others, including healthcare professionals, and may undergo unnecessary medical treatments, surgeries, or take medications that can cause them harm. The motivation behind this behavior is often a complex mix of factors, including the need for attention, control, or a desire to escape from difficult situations.

It's important to note that factitious disorders are different from malingering, which is the deliberate feigning or exaggeration of symptoms for external incentives such as financial gain, avoiding work or military duty, or obtaining drugs. Factitious disorders, on the other hand, are driven by internal motivations and can cause significant distress and impairment in a person's life.

Wernicke Encephalopathy is a neuropsychiatric disorder that is caused by a deficiency of thiamine (vitamin B1). It is characterized by a classic triad of symptoms: confusion, oculomotor dysfunction (such as nystagmus and ophthalmoplegia), and gait ataxia. Other symptoms can include memory loss, apathy, and hypothermia.

Wernicke Encephalopathy is most commonly seen in alcoholics due to poor nutrition, but it can also occur in people with conditions that cause malabsorption or increased thiamine requirements, such as AIDS, cancer, and chronic diarrhea. Immediate treatment with thiamine replacement therapy is necessary to prevent progression of the disease and potential permanent neurological damage. If left untreated, Wernicke Encephalopathy can lead to Korsakoff's syndrome, a chronic memory disorder.

Hyperemesis Gravidarum is a severe form of nausea and vomiting in pregnancy that is more extreme than the typical morning sickness. It's characterized by persistent vomiting, dehydration, weight loss, and electrolyte imbalance. If left untreated, it can lead to serious complications for both the mother and the baby. The exact cause is not known, but it may be related to high levels of hormones or other substances in the pregnant woman's body. Treatment often involves hospitalization for rehydration, medication to control vomiting, and nutritional support.

Myxedema is not a term used in modern medicine to describe a specific medical condition. However, historically, it was used to refer to the severe form of hypothyroidism, a condition characterized by an underactive thyroid gland that doesn't produce enough thyroid hormones. In hypothyroidism, various body functions slow down, which can lead to symptoms such as fatigue, weight gain, cold intolerance, constipation, and dry skin.

Myxedema specifically refers to the physical signs of severe hypothyroidism, including swelling (edema) and thickening of the skin, particularly around the face, hands, and feet, as well as a puffy appearance of the face. The term myxedema coma was used to describe a rare but life-threatening complication of long-standing, untreated hypothyroidism, characterized by altered mental status, hypothermia, and other systemic manifestations.

Nowadays, healthcare professionals use more precise medical terminology to describe these conditions, such as hypothyroidism or myxedematous edema, rather than the outdated term myxedema.

Autonomic denervation is a medical term that refers to the interruption or loss of nerve supply to the autonomic nervous system. The autonomic nervous system is the part of the nervous system that controls involuntary actions, such as heart rate, blood pressure, digestion, and pupil dilation.

Autonomic denervation can occur due to various reasons, including surgical procedures, trauma, degenerative diseases, or medical conditions such as diabetes. The interruption of nerve supply can lead to a range of symptoms depending on the specific autonomic functions that are affected.

For example, autonomic denervation in the heart can lead to abnormal heart rhythms or low blood pressure. In the digestive system, it can cause problems with motility and secretion, leading to symptoms such as bloating, constipation, or diarrhea. Autonomic denervation in the eyes can result in pupil abnormalities, dry eyes, or light sensitivity.

Treatment for autonomic denervation depends on the underlying cause and the specific symptoms that are present. In some cases, medication may be used to manage symptoms, while in others, surgical intervention may be necessary to repair or restore nerve function.

Sodium Pertechnetate Tc 99m is a radioactive pharmaceutical preparation used in medical diagnostic imaging. It is a technetium-99m radiopharmaceutical, where technetium-99m is a metastable nuclear isomer of technetium-99, which emits gamma rays and has a half-life of 6 hours. Sodium Pertechnetate Tc 99m is used as a contrast agent in various diagnostic procedures, such as imaging of the thyroid, salivary glands, or the brain, to evaluate conditions like inflammation, tumors, or abnormalities in blood flow. It is typically administered intravenously, and its short half-life ensures that the radiation exposure is limited.

Thiamine deficiency, also known as beriberi, is a condition that results from inadequate intake or impaired absorption of thiamine (vitamin B1), which is essential for energy metabolism and nerve function. This deficiency can lead to various symptoms such as peripheral neuropathy, muscle weakness, heart failure, and in severe cases, Wernicke-Korsakoff syndrome, a neurological disorder associated with alcoholism. Thiamine deficiency is commonly found in populations with poor nutrition, alcohol dependence, and gastrointestinal disorders affecting nutrient absorption.

Anti-arrhythmia agents are a class of medications used to treat abnormal heart rhythms or arrhythmias. These drugs work by modifying the electrical activity of the heart to restore and maintain a normal heart rhythm. There are several types of anti-arrhythmia agents, including:

1. Sodium channel blockers: These drugs slow down the conduction of electrical signals in the heart, which helps to reduce rapid or irregular heartbeats. Examples include flecainide, propafenone, and quinidine.
2. Beta-blockers: These medications work by blocking the effects of adrenaline on the heart, which helps to slow down the heart rate and reduce the force of heart contractions. Examples include metoprolol, atenolol, and esmolol.
3. Calcium channel blockers: These drugs block the entry of calcium into heart muscle cells, which helps to slow down the heart rate and reduce the force of heart contractions. Examples include verapamil and diltiazem.
4. Potassium channel blockers: These medications work by prolonging the duration of the heart's electrical cycle, which helps to prevent abnormal rhythms. Examples include amiodarone and sotalol.
5. Digoxin: This drug increases the force of heart contractions and slows down the heart rate, which can help to restore a normal rhythm in certain types of arrhythmias.

It's important to note that anti-arrhythmia agents can have significant side effects and should only be prescribed by a healthcare professional who has experience in managing arrhythmias. Close monitoring is necessary to ensure the medication is working effectively and not causing any adverse effects.

... (alimentary thyrotoxicosis, exogenous thyrotoxicosis) is a condition of thyrotoxicosis caused by the ... Vaidya, B; Pearce, S. H. S (2014). "Diagnosis and management of thyrotoxicosis". BMJ. 349: g5128. doi:10.1136/bmj.g5128. PMC ... In such cases, increased faecal thyroxine levels in thyrotoxicosis factitia may help differentiate it from other causes of ... Jahagirdar, V R; Strouhal, P; Holder, G; Gama, R; Singh, B M (2008). "Thyrotoxicosis factitia masquerading as recurrent Graves ...
... (AIT) is a form of hyperthyroidism due to treatment with antiarrhythmic drug, amiodarone. ... Macchia PE, Feingold KR (2022). "Amiodarone Induced Thyrotoxicosis". In Feingold KR, Anawalt B, Boyce A, Chrousos G (eds.). ... Schubert L, Bricaire L, Groussin L (June 2021). "Amiodarone-induced thyrotoxicosis". Annales d'Endocrinologie. 82 (3-4): 163- ... 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis ...
2 (6): 5-6. Fitzgerald PA (2022). Papadakis MA, McPhee SJ, Rabow MW, McQuaid KR (eds.). Hyperthyroidism (Thyrotoxicosis). {{ ...
The diabetes is ameliorated or may disappear when the thyrotoxicosis is treated. Evidence of mild or severe liver disease may ... Elderly patients may have what is called "apathetic thyrotoxicosis", a state in which they have less and less severe symptoms, ... Although it is true that in most patients ophthalmopathy, goiter, and symptoms of thyrotoxicosis appear more or less ... The hypothalamic-pituitary-testicular axis in thyrotoxicosis. Kidd GS, Glass AR, Vigersky RA, J Clin Endocrinol Metab. 1979;48( ...
These new theories imply that thyroid storm results from an interaction of thyrotoxicosis with the specific response of the ... Idrose, Alzamani Mohammad (2015-05-12). "Acute and emergency care for thyrotoxicosis and thyroid storm". Acute Medicine & ... Burch, H. B.; Wartofsky, L. (June 1993). "Life-threatening thyrotoxicosis. Thyroid storm". Endocrinology and Metabolism Clinics ... thyroid storm results from allostatic failure in a situation where thyrotoxicosis hampers the development of non-thyroidal ...
This cured her thyrotoxicosis. She was able to work again, and became a cook at a Victorian country hotel. Dunhill went on to ... She was an outpatient who had been treated for thyrotoxicosis. She did not respond to treatments, and Dunhill decided that ...
Krahn, D. (1990). "Thyrotoxicosis and Bulimia Nervosa". Psychosomatics. 31 (2): 222-224. doi:10.1016/S0033-3182(90)72201-3. ...
doi:10.1016/s0021-9258(18)74428-1. Campbell, W. R. (1943). "Thyrotoxicosis and its Treatment". Canadian Medical Association ...
Wayne, E. J. (20 February 1954). "The Diagnosis of Thyrotoxicosis". Br Med J. 1 (4859): 411-419. doi:10.1136/bmj.1.4859.411. ... Crooks, J.; Murray, I. P. C.; Wayne, E. J. (1959). "Statistical methods applied to the clinical diagnosis of thyrotoxicosis". ... in thyrotoxicosis. The procedure allocates a positive or negative score to each clinical feature and provides a numerical ... "Association of Thyrotoxicosis and Auto-immune Thyroiditis". Br Med J. 1 (5229): 843-847. doi:10.1136/bmj.1.5229.843. PMC ...
Dunne P, Kaimal N, MacDonald J, Syed AA (2013). "Iodinated contrast-induced thyrotoxicosis". CMAJ. 185 (2): 144-7. doi:10.1503/ ...
Krahn D (1990). "Thyrotoxicosis and bulimia nervosa". Psychosomatics. 31 (2): 222-4. doi:10.1016/S0033-3182(90)72201-3. PMID ...
Hamburger Thyrotoxicosis (alimentary thyrotoxicosis) outbreak among residents of southwestern Minnesota and adjacent areas of ... Hedberg CW, et al.: An outbreak of thyrotoxicosis caused by the consumption of bovine thyroid in ground beef. N Engl J Med 1987 ... Hamburger Thyrotoxicosis Segal, Marian (1988). "Invisible villains; tiny microbes are biggest food hazard". FDA Consumer. ... 316:993-8. Kinney, Janet S., et al.: Community outbreak of thyrotoxicosis: Epidemiology, immunogenetic characteristics, and ...
Ramsay I (December 1976). "Attempted prevention of neonatal thyrotoxicosis". British Medical Journal. 2 (6048): 1385. doi: ...
Pearce, Elizabeth N. (2006-06-08). "Diagnosis and management of thyrotoxicosis". BMJ. 332 (7554): 1369. doi:10.1136/bmj. ...
... especially triiodothyronine in cases of hamburger thyrotoxicosis or alimentary thyrotoxicosis) Mushroom toxins ... April 1987). "An outbreak of thyrotoxicosis caused by the consumption of bovine thyroid gland in ground beef". The New England ... Broome MR, Peterson ME, Kemppainen RJ, Parker VJ, Richter KP (January 2015). "Exogenous thyrotoxicosis in dogs attributable to ... Parmar MS, Sturge C (September 2003). "Recurrent hamburger thyrotoxicosis". CMAJ. 169 (5): 415-417. PMC 183292. PMID 12952802. ...
It occurs in patients with thyrotoxicosis. About 5% of hyperthyroid patients display abnormal nail changes. Plummer's nail is ...
These are normal in the other forms, and in thyrotoxicosis the levels of thyroxine and triiodothyronine are elevated, with ... McFadzean AJ, Yeung R (February 1967). "Periodic paralysis complicating thyrotoxicosis in Chinese". British Medical Journal. 1 ...
March 2009). "Struma ovarii and peritoneal strumosis with thyrotoxicosis". Thyroid. 19 (3): 305-308. doi:10.1089/thy.2008.0307 ...
... died of thyrotoxicosis in 1949. Judith Ion (27 February 2004). "McClemans, Sheila Mary (1909 - 1988)". ...
wit M. Green: Green, M.; Wilson, G. M. (18 April 1964). "Thyrotoxicosis Treated by Surgery or Iodine-131. With Special ...
Bock, O. A.; Witts, L. J. (6 July 1963). "Gastric Acidity and Gastric Biopsy in Thyrotoxicosis". Br Med J. 2 (5348): 20-24. doi ...
Overconsumption can lead to kelp-induced thyrotoxicosis. In 2010, researchers found that alginate, the soluble fibre substance ...
A common complication of juvenile thyrotoxicosis". The Journal of Pediatrics. 93 (2): 188-91. doi:10.1016/S0022-3476(78)80493-4 ...
A common complication of juvenile thyrotoxicosis". The Journal of Pediatrics. 93 (2): 188-91. doi:10.1016/S0022-3476(78)80493-4 ...
Thyrotoxicosis (cardiogenic shock) may induce a reversible cardiomyopathy. Acute adrenal insufficiency (distributive shock) is ...
Treatment of thyrotoxicosis (including Graves' disease) with 600-2,000 mg potassium perchlorate (430-1,400 mg perchlorate) ... Current regimens for treatment of thyrotoxicosis (including Graves' disease), when a patient is exposed to additional sources ... Barzilai, D; Sheinfeld, M (1966). "Fatal complications following use of potassium perchlorate in thyrotoxicosis. Report of two ... higher doses were introduced when 400 mg/day was discovered not to control thyrotoxicosis in all subjects. ...
"99mTc MIBI Scintigraphy for Classification of Amiodarone-induced Thyrotoxicosis". The Journal of Clinical Endocrinology & ... reports have demonstrated that 99mTc MIBI scan may be useful to differentiae the sub-type of amiodarone-induced thyrotoxicosis ...
Treatment of thyrotoxicosis (including Graves' disease) with 600-2,000 mg potassium perchlorate (430-1,400 mg perchlorate) ... Current regimens for treatment of thyrotoxicosis (including Graves' disease), when a patient is exposed to additional sources ... Barzilai, D; Sheinfeld, M (1966). "Fatal complications following use of potassium perchlorate in thyrotoxicosis. Report of two ... higher doses were introduced when 400 mg/d was discovered not to control thyrotoxicosis in all subjects. ...
Reversible causes of heart failure also need to be addressed (e.g. infection, alcohol ingestion, anemia, thyrotoxicosis, ... "High-Output Heart Failure Caused by Thyrotoxicosis and Beriberi". Crit Care Nurs Clin North Am. 27 (4): 499-510. doi:10.1016/j. ...
von Braun, Ammrei; Bühler, Annette; Yuen, Bernd (31 March 2011). Prisco, Domenico (ed.). "Severe thyrotoxicosis: a rare cause ...

No FAQ available that match "thyrotoxicosis"

No images available that match "thyrotoxicosis"